Vascular endothelial growth factor may provide additional values to C-reactive protein and anti-myeloperoxidase titer as a parameter for evaluating disease activity in anti-myeloperoxidase associated vasculitis

Ren Fail. 2003 Nov;25(6):1057-66. doi: 10.1081/jdi-120026042.

Abstract

Anti-myeloperoxidase (anti-MPO) associated vasculitis can result in rapid clinical deterioration. Immunosuppressive therapy is effective but involving considerable toxicity, and disease relapse frequently ensues. Laboratory parameters, such as C-reactive protein and anti-MPO titer, have substantial values in monitoring disease activity. However, the sensitivity and specificity are not satisfactory. This report presents the case of an old man with anti-MPO associated vasculitis. A parallel correlation between serum VEGF levels with C-reactive protein and anti-MPO titer was clearly demonstrated, implying a promising role of VEGF on monitoring disease activity in anti-MPO associated vasculitis. This is the first description of a correlation between VEGF and anti-MPO associated vasculitis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antibodies, Antineutrophil Cytoplasmic / blood*
  • Biomarkers / analysis
  • Biopsy, Needle
  • C-Reactive Protein / metabolism*
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Immunohistochemistry
  • Male
  • Peroxidase / analysis
  • Peroxidase / metabolism*
  • Prognosis
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Vascular Endothelial Growth Factor A / blood*
  • Vasculitis / blood
  • Vasculitis / diagnosis*

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Biomarkers
  • Vascular Endothelial Growth Factor A
  • C-Reactive Protein
  • Peroxidase